52-9.
12. Marston WA, Davies SW, Armstrong B, Farber MA, Mendes RC,
Fulton JJ, et al. Natural history of limbs with arterial insufﬁciency and
chronic ulceration treated without revascularization. J Vasc Surg
2006;44:108-14.
13. Elgzyri T, Larsson J, Thörne J, Eriksson KF, Apelqvist J. Outcome of
ischemic foot ulcer in diabetic patients who had no invasive vascular
intervention. Eur J Vasc Endovasc Surg 2013;46:110-7.
14. Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders.] Helv Chir Acta 1954;21:499-533.
15. Mills JL. Open bypass and endoluminal therapy: complementary
techniques for revascularization in diabetic patients with critical limb
ischemia. 5th International Symposium on the Diabetic Foot. Diabetes/Metabolism, Research and Reviews. Diabetes Metab Res Rev
2008;24(Suppl 1):S34-9.
16. Ihnat DM, Mills JL. Current assessment of endovascular therapy for
infrainguinal arterial occlusive disease in patients with diabetes. J Vasc
Surg 2010;52:92S-5S.
17. Hinchliffe RJ, Andros J, Apelqvist J, Bakker K, Fiedrichs S, Lammer J,
et al. A systematic review of the effectiveness of revascularization of the
ulcerated foot in patients with diabetes and peripheral arterial disease.
Diabetes Metab Res Rev 2012;28(Suppl 1):179-217.
18. Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M,
et al. Results of a double-blind, placebo-controlled study to assess the
safety of intramuscular injection of hepatocyte growth factor plasmid to
improve limb perfusion in patients with critical limb ischemia. Circulation 2008;118